• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE-TEX® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE-TEX® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number RRT07070080L
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem Thrombosis (2100)
Event Date 10/14/2018
Event Type  Injury  
Event Description
It was reported to gore that a gore-tex® vascular graft was implanted on (b)(6) 2018, in a (b)(6) male patient to treat an acute ischemia located at the right lower limb.On (b)(6) 2018, after about 8 days, the gore-tex® vascular graft was explanted due to a thrombosis leading to a transfemoral amputation.
 
Manufacturer Narrative
Additional information was entered for the following: result code 213: a review of the manufacturing records confirmed that the lot met all pre-release specifications.Result code 213: refer to explant evaluation summary.The gore-tex® vascular graft was returned to geprovas, independent laboratory, for investigation.The scope and results of the investigation were summarized and a report was submitted to w.L.Gore & associates.An explant investigator (ei) at w.L.Gore & associates reviewed the report.The following is a summary of the ei observations: minimal, scattered plaques of dark red/brown material on the albumen surface.Lumens were fully obstructed with dark red/brown and white/tan thrombotic material.Both poles were transected.Extremity a was ovular in shape.No defect on the eptfe membrane was observed during the macroscopic analysis.From gross images all material disruptions (i.E., material transections), appear to be consistent with cutting by sharp surgical instruments (i.E., scalpel or scissors), likely used during the explant procedure.Further analysis is not needed as the material disruptions are consistent with those caused by surgical instrumentation during the explant process.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE-TEX® VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key8245010
MDR Text Key132965691
Report Number2017233-2019-00016
Device Sequence Number1
Product Code DSY
UDI-Device Identifier00733132611034
UDI-Public00733132611034
Combination Product (y/n)N
PMA/PMN Number
K802095
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Type of Report Initial,Followup
Report Date 05/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/14/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/11/2023
Device Catalogue NumberRRT07070080L
Device Lot Number17638275
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age55 YR
-
-